NKTR News

Class Action Filing Announced by Pomerantz LLP Against Nektar Therapeutics – NKTR

Pomerantz Law Firm Announces The Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR

Nektar Therapeutics Class Action Reminder – Robbins LLP Encourages NKTR Investors to Contact the Firm for Information About Their Rights

Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

NKTR IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important May 5 Deadline in Securities Class Action - NKTR

DEADLINE ALERT for EOSE, SLNO, NKTR, DRVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

NKTR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 Ready to Announce with Confidence?

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Known Trial Defects: SueWallSt